01
Cash & equivalents increased 330.0%
Cash & equivalents changed +330.0% from the comparable as-filed period.
$2.2M→$9.5MComparable → current
· Biological Products, (No Diagnostic Substances)
RESEARCH SNAPSHOTINTENSITY THERAPEUTICS, INC.'s latest supported as-filed period reports net income of -$3.0M, 18.5% below the comparable as-filed period. Every value below links to its SEC accession and metric lineage.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed +330.0% from the comparable as-filed period.
Net income changed -18.5% from the comparable as-filed period.
Operating income changed -14.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
INTS · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001567264-26-000061SEC ↗10-QAug 11, 2026Period Jun 30, 20260001567264-26-000059SEC ↗4Jul 20, 2026Period Jul 16, 20260001231945-26-000002SEC ↗4Jul 20, 2026Period Jul 16, 20260001934188-26-000002SEC ↗4Jul 20, 2026Period Jul 16, 20260001278042-26-000002SEC ↗4Jul 20, 2026Period Jul 16, 20260001875180-26-000002SEC ↗4Jul 20, 2026Period Jul 16, 20260001895944-26-000008SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Jul 16, 2026Filed Jul 20, 2026 | DUBIN THOMAS I HDirector | Grant Or AwardDirect | 5,500 | $0 | $0 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Research & development changed +18.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Stock-based compensation changed -39.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001524547-26-000009